FIBROBLASTY KOZhI ZARODYShEY I IKh UChASTIE V REGENERATsII KOZhNYKh RAN I SKELETNYKh MYShTs

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription or Fee Access

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement / Dominici M., Le Blanc K., Mueller.I, Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop Dj., Horwitz E. // Cytotherapy.- 2006.- Vol. 8 (4).- P. 315-317.
Treatment of inflammatory diseases with mesenchymal stem cells / Newman R. E., Yoo D., LeRoux M. A., Danilkovitch-Miagkova A. // Inflamm Allergy Drug Targets.- 2009.- Vol. 8 (2).- P. 110-123.
Muscle regeneration by bone marrow-derived myogenic progenitors / Ferrari G., Cusella-De Angelis G., Coletta M., Paolucci E., Stornaiuolo A., Cossu G., Mavilio F. // Science.- 1998.- Vol. 279 (5356) - P. 1528-1530.
Caplan A. I. Why are MSCs therapeutic? New data: new insight // J. Pathol.- 2009.- Vol. 217 (2).- P. 318-324.

Supplementary Files

Action

1. JATS XML